Top health-care stocks:
Health-care shares were fairly flat in pre-market trading Tuesday.
Celladon ( CLDN ), a clinical-stage biotechnology company in the field of gene therapy and calcium dysregulation, priced an underwritten public offering of 4 million shares of its common stock at $9.50 per share. CLDN was down 2.5% at $9.41 in pre-market trading.
Insmed ( INSM ) priced an offering of 8.9 million shares of its common stock at a price of $11.25 per share in a registered underwritten public offering for gross proceeds totaling approximately $100 million. Shares of Insmed were down 2.6% in pre-market trading.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.